Merit Medical Systems Inc

Merit Medical Systems Inc

  • Price (USD)41.36
  • Today's Change0.530 / 1.30%
  • Shares traded272.61k
  • 1 Year change27.97%
  • Beta1.1264
Data delayed at least 15 minutes, as of Sep 25 2020 21:00 BST.
More ▼

Profile data is unavailable for this security.

About the company

Merit Medical Systems, Inc. is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices. Its endoscopy segment consists of gastroenterology and pulmonology medical devices, which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Within its segments, the Company offers products focused in four product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, and endoscopy.

  • Revenue in USD (TTM)962.87m
  • Net income in USD-29.82m
  • Incorporated1987
  • Employees6.36k
  • Location
    Merit Medical Systems Inc1600 W Merit PkwySOUTH JORDAN 84095-2416United StatesUSA
  • Phone+1 (801) 253-1600
  • Fax+1 (801) 253-1652
  • Websitehttps://www.merit.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Pacific Biosciences of California Inc82.52m-51.04m1.61bn404.00--34.49--19.48-0.3326-0.33260.53580.26820.42952.847.03204,257.40-26.57-53.50-50.06-69.7641.1442.99-61.85-86.221.03-63.560.00--15.608.4517.97--12.00--
Avanos Medical Inc705.30m-16.90m1.64bn4.70k--1.3067.002.33-0.3549-0.354914.7626.390.39862.035.38150,063.80-0.955-2.78-1.06-3.2855.7655.49-2.40-9.381.951.950.1645--6.94-16.04-270.16---8.41--
Adapthealth Corp709.55m-3.24m1.69bn3.06k--139.8839.772.38-0.07-0.0720.660.14351.43----231,878.100.3464--0.459--15.77--0.2429--0.93031.211.01-------818.85------
Axonics Modulation Technologies Inc52.76m-82.16m1.79bn302.00--6.00--33.92-2.62-2.621.647.550.21311.236.85174,715.20-33.18---36.27--55.41---155.70--9.91--0.0651--1,854.74---146.08------
AtriCure Inc.211.98m-50.10m1.80bn730.00--4.32--8.49-1.29-1.295.429.280.40482.068.34290,389.00-9.57-9.38-10.33-10.5672.2372.60-23.63-16.126.81-13.960.1372--14.4716.52-57.86--17.20--
Cantel Medical Corp.-100.00bn-100.00bn1.90bn2.78k--2.62----------17.18------------------------2.66--0.5914----------21.51--
Integer Holdings Corp1.20bn73.12m1.93bn8.25k26.581.6312.731.612.212.2136.1835.980.48924.865.79145,183.602.991.693.211.8327.0529.986.103.912.653.010.45030.003.5512.8457.1810.4614.19--
LivaNova PLC980.80m-160.71m2.06bn4.00k--1.54--2.10-3.32-3.3420.1627.390.38281.764.44245,200.80-6.27---7.54--69.05---16.37--1.851.320.3266---2.06--12.84------
Glaukos Corp211.25m-70.88m2.18bn600.00--3.29--10.33-1.84-1.844.6914.870.32564.438.66352,086.70-10.92-3.00-11.70-3.4263.1785.09-33.55-4.117.88-37.510.2695--30.7339.05219.10--40.33--
Outset Medical Inc28.65m-82.00m2.19bn273.00------76.54-2.00-2.000.6992.88------125,644.70---------57.26---286.25--2.86-31.230.1993--651.27---37.20------
Conmed Corp870.25m431.00k2.20bn3.30k4,112.243.2629.982.53-0.0274-0.027429.5123.630.49972.285.40263,712.100.02482.080.02712.3354.2554.660.04953.351.351.330.544281.4211.115.23-28.37-2.325.420.00
Patterson Companies, Inc.5.41bn-594.08m2.26bn7.80k--2.65--0.4179-6.30-6.3057.018.861.805.6212.36693,230.40-19.85-0.1529-28.76-0.207121.4722.58-11.00-0.09230.77613.260.4586---1.527.02-827.00---7.174.87
Merit Medical Systems, Inc.962.87m-29.82m2.29bn6.36k--2.4735.682.38-0.5388-0.538817.4316.740.55782.636.52151,513.30-1.732.18-1.922.4341.9344.09-3.103.311.293.460.30650.0012.7014.31-87.94-25.0017.82--
Shockwave Medical Inc51.13m-64.60m2.45bn284.00--9.97--47.85-2.11-2.111.687.220.23551.218.81180,028.20-29.76---32.22--62.45---126.34--13.58-63.390.0622--250.05---24.35------
NuVasive, Inc.1.06bn-3.83m2.52bn2.80k--2.8218.782.37-0.1235-0.123520.0317.460.47791.035.46380,243.60-0.1723.05-0.22043.4570.6373.83-0.35984.711.441.250.6070.006.028.91422.75--17.42--
STAAR Surgical Company148.32m7.46m2.52bn550.00349.2614.44235.9917.020.15780.15783.223.810.73432.424.10269,670.903.690.77594.341.0072.1972.255.030.73875.21--0.01090.0021.1614.90182.77--20.21--
Data as of Sep 25 2020. Currency figures normalised to Merit Medical Systems Inc's reporting currency: US Dollar USD

Institutional shareholders

63.01%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 30 Jun 20207.78m14.02%
The Vanguard Group, Inc.as of 30 Jun 20205.55m10.01%
ArrowMark Colorado Holdings LLCas of 30 Jun 20204.66m8.40%
Starboard Value LPas of 30 Jun 20204.32m7.79%
Nuance Investments LLCas of 30 Jun 20203.14m5.67%
SSgA Funds Management, Inc.as of 30 Jun 20202.23m4.02%
Dimensional Fund Advisors LPas of 30 Jun 20201.98m3.57%
Conestoga Capital Advisors LLCas of 30 Jun 20201.97m3.54%
Macquarie Investment Management Business Trustas of 30 Jun 20201.85m3.34%
Aristotle Capital Boston LLCas of 30 Jun 20201.48m2.66%
More ▼
Data from 30 Jun 2020 - 30 Jun 2020Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.